Parrott, A.,Downey, L.,Roberts, C.,Montgomery, C.,Bruno, R. & Fox, H. (2017). Recreational 3,4-methylenedioxymethamphetamine or ‘ecstasy’: Current perspective and future research prospects. Journal of Psychopharmacology 31(8), 959-966.
Corazza, O..,Parrott, A.C.. & Demetrovics, Z.. (2017). Novel psychoactive substances: Shedding new lights on the ever-changing drug scenario and the associated health risks. Human Psychopharmacology: Clinical and Experimental 32(3), e2616
Parrott, A.,Hayley, A. & Downey, L. (2017). Recreational stimulants, herbal, and spice cannabis: The core psychobiological processes that underlie their damaging effects. Human Psychopharmacology: Clinical and Experimental 32(3), e2594
Roberts, C.,Quednow, B.,Montgomery, C. & Parrott, A. (2017). MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent ‘Ecstasy’ users. Neuroscience & Biobehavioral Reviews
Downey, L.,Tysse, B.,Ford, T.,Samuels, A.,Wilson, R. & Parrott, A. (2017). Psychomotor Tremor and Proprioceptive Control Problems in Current and Former Stimulant Drug Users: An Accelerometer Study of Heavy Users of Amphetamine, MDMA, and Other Recreational Stimulants. The Journal of Clinical Pharmacology
Jones, L.,Reed, P. & Parrott, A. (2016). Mephedrone and 3,4-methylenedioxy-methamphetamine: Comparative psychobiological effects as reported by recreational polydrug users. Journal of Psychopharmacology 30(12), 1313-1320.
Sands, H.,Downey, L.,Wilson, R.,Abbott, L.,Tysse, B. & Parrott, A. (2015). Mood and Psychomotor Tremor Changes following Acute Caffeine Consumption in Moderate and Minimal Caffeine Consumers. Journal of Caffeine Research 5(1), 42-49.
Singer, L.,Moore, D.,Min, M.,Goodwin, J.,Turner, J.,Fulton, S. & Parrott, A. (2015). Developmental outcomes of 3,4-methylenedioxymethamphetamine (ecstasy)-exposed infants in the UK. Human Psychopharmacology: Clinical and Experimental 30(4), 290-294.
May, A. & Parrott, A. (2015). Greater sexual risk-taking in female and male recreational MDMA/ecstasy users compared with alcohol drinkers: a questionnaire study. Human Psychopharmacology: Clinical and Experimental 30(4), 272-275.
Downey, L.,Sands, H.,Jones, L.,Clow, A.,Evans, P.,Stalder, T. & Parrott, A. (2015). Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits. Human Psychopharmacology: Clinical and Experimental 30(3), 199-207.
Parrott, A.Moore, D.Turner, J.Goodwin, J.Min, M. & Singer, L. (2014). MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used ‘Ecstasy’ during pregnancy. Human Psychopharmacology: Clinical and Experimental 29(1), 1-7.
Turner, J.,Parrott, A.,Goodwin, J.,Moore, D.,Fulton, S.,Min, M. & Singer, L. (2014). Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: Reduced depression 1 year after giving birth and quitting Ecstasy. Journal of Psychopharmacology 28(1), 55-61.
Wilson, R.,Grundy, E.,Massy, R.,Soltis, J.,Tysse, B.,Holton, M.,Cai, Y.,Parrott, A.,Downey, L.,Qasem, L. & Butt, T. (2014). Wild state secrets: ultra-sensitive measurement of micro-movement can reveal internal processes in animals. Frontiers in Ecology and the Environment 12(10), 582-587.
Parrott, A.,Corazza, O.,Schifano, F.,Griffiths, M.,Sedefov, R.,Gallegos , A., et. al. (2014). Second International Conference on Novel Psychoactive Substances (NPSs): keynote addresses and conference abstracts.. Open Addiction Journal, 255-256.
Singer, L.Moore, D.Fulton, S.Goodwin, J.Turner, J.Min, M. & Parrott, A. (2012). Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy. Neurotoxicology and Teratology 34(3), 303-310.
Parrott, A.Hatton, N.Rowe, K.Watts, L.Donev, R.Kissling, C. & Thome, J. (2012). Adult attention deficit hyperactivity disorder and other psychiatric symptoms in recreational polydrug users. Human Psychopharmacology: Clinical and Experimental 27(2), 209-216.
Parrott, A.Murphy, P. & Scholey, A. (2012). Applied human psychopharmacology: the practical psychobiological consequences of some novel and ancient psychoactive drugs. Human Psychopharmacology: Clinical and Experimental 27(2), 103-105.
Burgess, A.,Venables, L.,Jones, H.,Edwards, R. & Parrott, A. (2011). Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine (“Ecstasy”)/polydrug users. Psychopharmacology 216(4), 545-556.
Parrott, A.Gibbs, A.Scholey, A.King, R.Owens, K.Swann, P.Ogden, E. & Stough, C. (2011). MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study. Psychopharmacology 215(3), 527-536.
Blagrove, M.Seddon, J.George, S.Parrott, A.Stickgold, R.Walker, M.Jones, K. & Morgan, M. (2011). Procedural and declarative memory task performance, and the memory consolidation function of sleep, in recent and abstinent ecstasy/MDMA users. Journal of Psychopharmacology 25(4), 465-477.
Scholey, A.Owen, L.Gates, J.Rodgers, J.Buchanan, T.Ling, J.Heffernan, T.Swan, P.Stough, C. & Parrott, A. (2011). Hair MDMA Samples Are Consistent with Reported Ecstasy Use: Findings from a Study Investigating Effects of Ecstasy on Mood and Memory. Neuropsychobiology 63(1), 15-21.
Moore, D.,Turner, J.,Parrott, A.,Goodwin, J.,Fulton, S.,Min, M.,Fox, H.,Braddick, F.,Axelsson, E.,Lynch, S.,Ribeiro, H.,Frostick, C. & Singer, L. (2010). During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study. Journal of Psychopharmacology 24(9), 1403-1410.
Buchanan, T.Heffernan, T.Parrott, A.Ling, J.Rodgers, J. & Scholey, A. (2010). A short self-report measure of executive function suitable for administration via the Internet.. Behavioural Research Methods & Instrumentation. 42, 709-714.
Li-Tzy, W.Parrott, A.Ringwalt, C.Yang, C. & Blazer, D. (2009). The Variety of Ecstasy/MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. American Journal on Addictions 18(6), 452-461.
Li-Tzy, W.Parrott, A.Ringwalt, C.Patkar, A.Mannelli, P. & Blazer, D. (2009). The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention. Addictive Behaviors 34(8), 654-661.
Parrott, A.,Lock, J.,Conner, A.,Kissling, C. & Thome, J. (2008). Dance Clubbing on MDMA and during Abstinence from Ecstasy/MDMA: Prospective Neuroendocrine and Psychobiological Changes. Neuropsychobiology 57(4), 165-180.